title: Endoscopic sclerosis in the treatment of bleeding peptic ulcers with a visible vessel.
abstract: We have assessed the efficacy of endoscopic sclerosis in the routine clinical management of patients with bleeding ulcers, in whom a visible vessel was identified at endoscopy. Over a period of 14 months, a visible vessel at the base of an ulcer was identified in 53 patients. Three patients could not undergo sclerosis, one because of torrential bleeding and two because of ulcer location. Fifty patients, 18 with a bleeding vessel and 32 with a nonbleeding vessel, were subjected to endoscopic sclerosis with adrenaline plus polidocanol. Permanent hemostasis was achieved in 45 patients (90%), 31 (62%) cases with one session and 14 (28%) cases with two sessions of sclerosis. Four patients had persistent rebleeding in spite of two sessions of sclerosis, and one patient had a massive rebleeding after the first session; all underwent emergency surgery. We believe that endoscopic sclerosis has a primary role in the treatment of ulcer bleeding, particularly in those patients in whom a visible vessel is identified at endoscopy.
authors.affiliation: Service of Gastroenterology, Hospital Mutua de Terrassa, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Panés
authors.forename: M
authors.initials: M
authors.lastname: Forné
authors.forename: F
authors.initials: F
authors.lastname: Bágena
authors.forename: J
authors.initials: J
authors.lastname: Viver
mesh_terms: D000368:Aged; D004381:Duodenal Ulcer / Q000150:complications*; D004384:Duodenoscopy; D005260:Female; D005773:Gastroscopy; D006489:Hemostatic Techniques; D006801:Humans; D008297:Male; D008875:Middle Aged; D010438:Peptic Ulcer Hemorrhage / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D011446:Prospective Studies; D012008:Recurrence; D015911:Sclerotherapy / Q000379:methods*; D013276:Stomach Ulcer / Q000150:complications*